Tag

Blood Tests

All articles tagged with #blood tests

ASH Guidelines Shift Ferritin Thresholds to Catch Hidden Iron Deficiency
health3 days ago

ASH Guidelines Shift Ferritin Thresholds to Catch Hidden Iron Deficiency

The American Society of Hematology (ASH) has released new guidelines that lower the ferritin thresholds required to diagnose iron deficiency, aiming to identify the condition earlier. These updated standards replace statistical 'normal' ranges with clinical outcome-based markers, potentially reclassifying many previously 'normal' results as deficient. The change is particularly significant for women with heavy menstrual bleeding and pregnant individuals, who now have higher diagnostic cutoffs. Experts emphasize that iron deficiency affects approximately 14% of U.S. adults and often precedes anemia, causing fatigue and cognitive issues without obvious symptoms. While the guidelines standardize diagnosis, they do not mandate immediate supplementation; treatment depends on the underlying cause, which may include blood loss or absorption issues. High ferritin levels do not necessarily indicate excess iron, as inflammation or liver disease can also elevate these markers.

New Data Suggests Fasting Before Blood Tests Is Unnecessary for Most Routine Labs
health5 days ago

New Data Suggests Fasting Before Blood Tests Is Unnecessary for Most Routine Labs

A large-scale study published in JAMA Internal Medicine indicates that the standard 8-to-12-hour fasting requirement for routine blood tests is likely unnecessary for the majority of analytes. Researchers found that only a small subset of tests, primarily those measuring glucose, triglycerides, and specific enzymes, are significantly affected by recent food intake. The findings suggest that clinical protocols could shift toward analyte-specific preparation rather than uniform fasting, potentially reducing patient burden and improving laboratory efficiency. However, experts caution that current guidelines should not be changed until further multicenter studies confirm these results across diverse populations.

Alzheimer’s blood tests aren’t ready for healthy people—prioritize heart health to lower dementia risk
health22 days ago

Alzheimer’s blood tests aren’t ready for healthy people—prioritize heart health to lower dementia risk

Blood tests that detect Alzheimer’s risk are not recommended for asymptomatic individuals; a positive result indicates risk but doesn’t guarantee dementia and can include false positives, while negatives are more reliable. In contrast, robust evidence shows that protecting midlife heart health—managing blood pressure, diabetes, and smoking—via regular exercise, resistance training, the MIND diet, sufficient sleep, social engagement, hearing care, and cognitive activities can substantially delay or reduce dementia risk. Ongoing trials may alter testing guidance, but for now, lifestyle and cardiovascular health are the best prevention tools.

Social media hype around Alzheimer's blood tests risks anxiety and misdiagnosis
health24 days ago

Social media hype around Alzheimer's blood tests risks anxiety and misdiagnosis

Researchers warn that social media promotion of Alzheimer's blood biomarker tests (e.g., p-tau217/181) can lure asymptomatic people into unnecessary testing, triggering anxiety and possible misdiagnosis since a positive biomarker does not guarantee future dementia; experts urge use only with clinical assessment and caution against screening healthy individuals, noting costs, potential harms, and unclear next steps.

Alzheimer’s breakthroughs shift focus to earlier detection and slower decline
the-highlight1 month ago

Alzheimer’s breakthroughs shift focus to earlier detection and slower decline

New Alzheimer’s drugs lecanemab and donanemab can slow cognitive decline for some patients, and new blood tests may identify at-risk people earlier to enable prevention and treatment; while these advances signal a real shift in how we diagnose and treat dementia, experts caution that benefits are partial, risks remain (including brain bleeds), and a longer, more robust drug pipeline—targeting tau, inflammation, and prevention via GLP-1s—will determine how far we can go. Strong science funding and nonpolitical support for research are crucial as patients are encouraged to discuss testing and trial opportunities with their doctors and to participate in studies.

Could Your Iron Supplement Be Too Much of a Good Thing? Here’s How to Tell
health1 month ago

Could Your Iron Supplement Be Too Much of a Good Thing? Here’s How to Tell

A HuffPost health piece explains that iron deficiency is common and outlines how much iron to take (roughly 65 mg of elemental iron daily for deficiency, 27 mg daily during pregnancy). It notes that taking too much can cause constipation, upset stomach, and dark stools, and long-term iron overload can harm the heart or liver. The article emphasizes confirming iron deficiency with a blood test before starting supplements and consulting a doctor for personalized dosing, since fatigue has many causes and other conditions can mimic iron deficiency (e.g., thalassemia) and won’t respond to iron alone.

Blood Biomarker Signals Alzheimer’s Risk in Healthy Older Adults
health2 months ago

Blood Biomarker Signals Alzheimer’s Risk in Healthy Older Adults

A study using a p-tau217 blood test found that symptom-free older adults with very high levels have a 38% five-year and 78% ten-year risk of developing cognitive impairment, suggesting a potential way to speed Alzheimer’s drug trials, but experts warn it isn’t precise enough for individual prognosis and testing should be approached cautiously.

Beyond Memory Loss: Spotting Early-Onset Alzheimer’s Signs That Aren’t Chalked Up to Forgetfulness
health3 months ago

Beyond Memory Loss: Spotting Early-Onset Alzheimer’s Signs That Aren’t Chalked Up to Forgetfulness

Memory loss isn’t always the first sign of early-onset Alzheimer’s; many patients first show executive-function, language, vision, or personality changes, which can delay diagnosis. Most cases before 65 aren’t genetic, though about 5% involve gene mutations; roughly 360,000 Americans are affected. Advances in biomarkers—amyloid and tau PET scans, spinal fluid tests, and increasingly blood tests like p-tau217—now allow diagnosis in living patients and could democratize access. Clinicians use detailed histories, MRI, and biomarker results to diagnose and discuss treatments, including monoclonal antibodies targeting amyloid and emerging tau therapies, moving toward biology-based classification and personalized, combination therapies. The LEADS study aids early-onset diagnosis and trial access, underscoring a shift to earlier, biology-driven care for younger patients.

US Expands Colorectal Cancer Screening with At-Home and Blood Tests
health4 months ago

US Expands Colorectal Cancer Screening with At-Home and Blood Tests

The American Cancer Society updated its May 2026 colorectal cancer screening guidelines to add two new options—an at-home stool test and a blood-based test—while maintaining colonoscopy as a primary option. Average-risk individuals should start screening at age 45 and continue until 75 (or longer if advised by a doctor). The stool and blood tests are intended to improve access and early detection, though many doctors’ offices may not yet offer them; ultimately, the best test is the one that gets done, with colonoscopy remaining the default for those with higher risk or abnormal results.

Alzheimer's blood tests spark debate over predicting risk and guiding care
health5 months ago

Alzheimer's blood tests spark debate over predicting risk and guiding care

Alzheimer's blood tests that detect amyloid or tau are being considered for early risk assessment, but doctors say their predictive value for asymptomatic people is uncertain, with potential false positives/negatives and no clear benefit from early intervention; FDA has cleared two tests for symptomatic patients, not for screening; patient interest is high, with surveys showing many would take a test if advised, though distress is common.

New Blood Tests Improve Early Detection of Pancreatic Cancer
health9 months ago

New Blood Tests Improve Early Detection of Pancreatic Cancer

New blood tests like the Grail Galleri offer hope for early detection of pancreatic cancer, which is crucial as most cases are diagnosed late with poor survival rates. Early detection can significantly improve treatment outcomes, but current screening options are limited, and the disease remains deadly, especially in Ohio where incidence and mortality rates are high. Researchers emphasize the importance of clinical trials and awareness efforts to improve prognosis and develop better therapies.

Thyroid Symptoms Persist Despite Normal Blood Tests
health10 months ago

Thyroid Symptoms Persist Despite Normal Blood Tests

Dr. Roach explains that persistent hypothyroid symptoms despite normal blood tests may be due to issues like T4 to T3 conversion problems, and advises checking T3, T4, and TSH levels. He also discusses the minimal lead content in fiber supplements, suggesting the small risk is unlikely to cause health issues, and emphasizes finding the true cause of symptoms if thyroid tests are normal.